Sale!

MYPN Gene Cardiomyopathy Dilated Type 1KK NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The MYPN Gene Cardiomyopathy Dilated Type 1KK NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the MYPN gene associated with dilated cardiomyopathy type 1KK. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect specific genetic variants that can lead to heart muscle weakening and enlargement. The test is particularly valuable for individuals with family history of cardiomyopathy, unexplained heart failure symptoms, or those seeking proactive cardiac health assessment. Results provide critical information for early intervention, personalized treatment planning, and family genetic counseling. The test is available for $500 USD (discounted from $700) with results typically available within 3-4 weeks. Sample collection options include blood, extracted DNA, or a simple blood drop on FTA card for convenient testing.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

MYPN Gene Cardiomyopathy Dilated Type 1KK NGS Genetic DNA Test

Comprehensive Genetic Testing for Dilated Cardiomyopathy

The MYPN Gene Cardiomyopathy Dilated Type 1KK NGS Genetic DNA Test represents a significant advancement in cardiovascular genetic medicine. This specialized diagnostic tool focuses on identifying mutations in the MYPN (myopalladin) gene, which plays a crucial role in maintaining the structural integrity and function of cardiac muscle cells. When mutations occur in this gene, they can lead to dilated cardiomyopathy type 1KK, a serious condition characterized by enlarged heart chambers and reduced pumping efficiency.

What Does This Test Measure and Detect?

This advanced genetic test specifically targets the MYPN gene using Next-Generation Sequencing (NGS) technology to identify:

  • Pathogenic variants and mutations in the MYPN gene
  • Single nucleotide polymorphisms (SNPs) associated with dilated cardiomyopathy
  • Insertions, deletions, and copy number variations affecting cardiac function
  • Genetic markers that predispose individuals to heart muscle disease
  • Inheritance patterns that may affect family members

Who Should Consider This Genetic Test?

This test is particularly recommended for individuals experiencing:

  • Unexplained shortness of breath or fatigue during routine activities
  • Family history of cardiomyopathy or sudden cardiac death
  • Abnormal heart rhythms or palpitations without clear cause
  • Swelling in legs, ankles, or feet due to fluid retention
  • Previous diagnosis of heart enlargement without known cause
  • Planning pregnancy with family history of cardiac conditions
  • Unexplained fainting episodes or dizziness

Key Benefits of MYPN Genetic Testing

  • Early Detection: Identify genetic predisposition before symptoms develop
  • Personalized Treatment: Guide medication choices and lifestyle modifications
  • Family Planning: Provide crucial information for genetic counseling
  • Proactive Monitoring: Enable regular cardiac screening for at-risk individuals
  • Peace of Mind: Clarify genetic status and reduce uncertainty
  • Comprehensive Analysis: NGS technology ensures thorough genetic evaluation

Understanding Your Test Results

Your genetic test results will fall into one of several categories:

  • Positive Result: Indicates the presence of a known pathogenic mutation in the MYPN gene. This confirms genetic predisposition to dilated cardiomyopathy and requires consultation with a cardiologist and genetic counselor.
  • Negative Result: No known pathogenic mutations detected. While reassuring, this doesn’t completely eliminate risk of developing cardiomyopathy through other genetic or environmental factors.
  • Variant of Uncertain Significance (VUS): A genetic change identified but its clinical significance is unknown. Regular follow-up and family studies may be recommended.
  • Carrier Status: Important information for family planning and understanding inheritance patterns.

Test Pricing and Details

Test Feature Details
Test Name MYPN Gene Cardiomyopathy Dilated Type 1KK NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Nationwide Testing Availability

We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible genetic testing services regardless of your location.

Take Control of Your Cardiac Health Today

Don’t wait for symptoms to develop before understanding your genetic risk for dilated cardiomyopathy. Our MYPN Gene Cardiomyopathy Dilated Type 1KK NGS Genetic DNA Test provides the comprehensive genetic information you need to make informed decisions about your heart health. With our discounted price of $500 USD and convenient sample collection options, there’s never been a better time to prioritize your cardiac wellness.

Ready to schedule your genetic test? Contact our genetic counseling team today at +1(267) 388-9828 or book your appointment online. Our specialists are available to answer your questions and guide you through the testing process.